200 related articles for article (PubMed ID: 16851402)
1. Computational study of the dynamics of mannose disaccharides free in solution and bound to the potent anti-HIV virucidal protein cyanovirin.
Margulis CJ
J Phys Chem B; 2005 Mar; 109(8):3639-47. PubMed ID: 16851402
[TBL] [Abstract][Full Text] [Related]
2. Potent inhibition of HIV-1 fusion by cyanovirin-N requires only a single high affinity carbohydrate binding site: characterization of low affinity carbohydrate binding site knockout mutants.
Chang LC; Bewley CA
J Mol Biol; 2002 Apr; 318(1):1-8. PubMed ID: 12054763
[TBL] [Abstract][Full Text] [Related]
3. Atomic mapping of the interactions between the antiviral agent cyanovirin-N and oligomannosides by saturation-transfer difference NMR.
Sandström C; Berteau O; Gemma E; Oscarson S; Kenne L; Gronenborn AM
Biochemistry; 2004 Nov; 43(44):13926-31. PubMed ID: 15518540
[TBL] [Abstract][Full Text] [Related]
4. Dissecting carbohydrate-Cyanovirin-N binding by structure-guided mutagenesis: functional implications for viral entry inhibition.
Barrientos LG; Matei E; Lasala F; Delgado R; Gronenborn AM
Protein Eng Des Sel; 2006 Dec; 19(12):525-35. PubMed ID: 17012344
[TBL] [Abstract][Full Text] [Related]
5. Selective interactions of the human immunodeficiency virus-inactivating protein cyanovirin-N with high-mannose oligosaccharides on gp120 and other glycoproteins.
Shenoy SR; O'Keefe BR; Bolmstedt AJ; Cartner LK; Boyd MR
J Pharmacol Exp Ther; 2001 May; 297(2):704-10. PubMed ID: 11303061
[TBL] [Abstract][Full Text] [Related]
6. Solution structure of a cyanovirin-N:Man alpha 1-2Man alpha complex: structural basis for high-affinity carbohydrate-mediated binding to gp120.
Bewley CA
Structure; 2001 Oct; 9(10):931-40. PubMed ID: 11591348
[TBL] [Abstract][Full Text] [Related]
7. Solution and crystal molecular dynamics simulation study of m4-cyanovirin-N mutants complexed with di-mannose.
Vorontsov II; Miyashita O
Biophys J; 2009 Nov; 97(9):2532-40. PubMed ID: 19883596
[TBL] [Abstract][Full Text] [Related]
8. Solution structure of cyanovirin-N, a potent HIV-inactivating protein.
Bewley CA; Gustafson KR; Boyd MR; Covell DG; Bax A; Clore GM; Gronenborn AM
Nat Struct Biol; 1998 Jul; 5(7):571-8. PubMed ID: 9665171
[TBL] [Abstract][Full Text] [Related]
9. Actinohivin, a novel anti-human immunodeficiency virus protein from an actinomycete, inhibits viral entry to cells by binding high-mannose type sugar chains of gp120.
Chiba H; Inokoshi J; Nakashima H; Omura S; Tanaka H
Biochem Biophys Res Commun; 2004 Mar; 316(1):203-10. PubMed ID: 15003531
[TBL] [Abstract][Full Text] [Related]
10. Identification and characterization of peptides that bind to cyanovirin-N, a potent human immunodeficiency virus-inactivating protein.
Han Z; Simpson JT; Fivash MJ; Fisher R; Mori T
Peptides; 2004 Apr; 25(4):551-61. PubMed ID: 15165709
[TBL] [Abstract][Full Text] [Related]
11. Combining weak affinity chromatography, NMR spectroscopy and molecular simulations in carbohydrate-lysozyme interaction studies.
Landström J; Bergström M; Hamark C; Ohlson S; Widmalm G
Org Biomol Chem; 2012 Apr; 10(15):3019-32. PubMed ID: 22395160
[TBL] [Abstract][Full Text] [Related]
12. The potent anti-HIV protein cyanovirin-N contains two novel carbohydrate binding sites that selectively bind to Man(8) D1D3 and Man(9) with nanomolar affinity: implications for binding to the HIV envelope protein gp120.
Bewley CA; Otero-Quintero S
J Am Chem Soc; 2001 May; 123(17):3892-902. PubMed ID: 11457139
[TBL] [Abstract][Full Text] [Related]
13. Analysis of sequence requirements for biological activity of cyanovirin-N, a potent HIV (human immunodeficiency virus)-inactivating protein.
Mori T; Shoemaker RH; Gulakowski RJ; Krepps BL; McMahon JB; Gustafson KR; Pannell LK; Boyd MR
Biochem Biophys Res Commun; 1997 Sep; 238(1):218-22. PubMed ID: 9299482
[TBL] [Abstract][Full Text] [Related]
14. Actinohivin: specific amino acid residues essential for anti-HIV activity.
Takahashi A; Inokoshi J; Tsunoda M; Suzuki K; Takenaka A; Sekiguchi T; Omura S; Tanaka H
J Antibiot (Tokyo); 2010 Nov; 63(11):661-5. PubMed ID: 20842142
[TBL] [Abstract][Full Text] [Related]
15. Properties of cyanovirin-N (CV-N): inactivation of HIV-1 by sessile cyanovirin-N (sCV-N).
Gandhi MJ; Boyd MR; Yi L; Yang GG; Vyas GN
Dev Biol (Basel); 2000; 102():141-8. PubMed ID: 10794101
[TBL] [Abstract][Full Text] [Related]
16. How can (-)-epigallocatechin gallate from green tea prevent HIV-1 infection? Mechanistic insights from computational modeling and the implication for rational design of anti-HIV-1 entry inhibitors.
Hamza A; Zhan CG
J Phys Chem B; 2006 Feb; 110(6):2910-7. PubMed ID: 16471901
[TBL] [Abstract][Full Text] [Related]
17. Crystal molecular dynamics simulations to speed up MM/PB(GB)SA evaluation of binding free energies of di-mannose deoxy analogs with P51G-m4-Cyanovirin-N.
Vorontsov II; Miyashita O
J Comput Chem; 2011 Apr; 32(6):1043-53. PubMed ID: 20949512
[TBL] [Abstract][Full Text] [Related]
18. Accessibility of the high-mannose glycans of glycoprotein gp120 from human immunodeficiency virus type 1 probed by in vitro interaction with mannose-binding lectins.
Astoul CH; Peumans WJ; Van Damme EJ; Roug
Biochem Biophys Res Commun; 2000 Aug; 274(2):455-60. PubMed ID: 10913359
[TBL] [Abstract][Full Text] [Related]
19. A monovalent mutant of cyanovirin-N provides insight into the role of multiple interactions with gp120 for antiviral activity.
Fromme R; Katiliene Z; Giomarelli B; Bogani F; Mc Mahon J; Mori T; Fromme P; Ghirlanda G
Biochemistry; 2007 Aug; 46(32):9199-207. PubMed ID: 17636873
[TBL] [Abstract][Full Text] [Related]
20. The role of Glu41 in the binding of dimannose to P51G-m4-CVN.
Ramadugu SK; Li Z; Kashyap HK; Margulis CJ
Biochemistry; 2014 Mar; 53(9):1477-84. PubMed ID: 24524298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
